These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 1087443)

  • 1. Immunologic definition of lymphocytes: functions and markers.
    Stathopoulos G; Davies AJ
    Recent Results Cancer Res; 1976; (56):17-23. PubMed ID: 1087443
    [No Abstract]   [Full Text] [Related]  

  • 2. [T-lymphocytes in the peripheral blood and lymph nodes in lymphatic system diseases].
    Michlmayr G; Huber C; Fink U; Falkensammer M; Huber H
    Schweiz Med Wochenschr; 1974 Jun; 104(23):815-20. PubMed ID: 4546217
    [No Abstract]   [Full Text] [Related]  

  • 3. Poor prognosis of children with acute lymphocytic leukemia and increased B cell markers.
    Wolff LJ; Richardson ST; Neiberger JB; Neiburger RG; Irwin DS; Bachner RL
    J Pediatr; 1976 Dec; 89(6):956-8. PubMed ID: 1086896
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunological characterization of lymphoproliferative disorders by membrane markers.
    Huber H; Michlmayr G; Huber C; Falkensammer M
    Klin Wochenschr; 1976 Aug; 54(15):699-708. PubMed ID: 790006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral blood T- and B-lymphocytes in patients with lymphoma and acute leukemia.
    Chin AH; Saiki JH; Trujillo JM; Williams RC
    Clin Immunol Immunopathol; 1973 Jul; 1(4):499-510. PubMed ID: 4617644
    [No Abstract]   [Full Text] [Related]  

  • 6. Five types of lymphocytes (Ig-theta-, Ig-theta+weak, Ig-theta+strong, Ig+theta- and Ig+theta+) characterized by double immunofluorescence and electrophoretic mobility. Organ distribution in normal and nude mice.
    Roelants GE; Loor F; von Boehmer H; Sprent J; Hägg LB; Mayor KS; Rydén A
    Eur J Immunol; 1975 Feb; 5(2):127-31. PubMed ID: 1086220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte surface markers in lymphoproliferative disorders.
    Aiuti F; Lacava V; Fiorilli M; Ciarla MV
    Acta Haematol; 1973; 50(5):275-83. PubMed ID: 4202631
    [No Abstract]   [Full Text] [Related]  

  • 8. Lymphocyte surface receptors in childhood acute lymphocytic leukemia.
    Esber E; DiNicola W; Movassaghi N; Leikin S
    Pediatrics; 1975 Nov; 56(5):788-92. PubMed ID: 1081671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Search for correlations between immunological and morphological criteria used to classify lymphoid leukemias and non-Hodgkin's hematosarcomas with special reference to scanning electron microscopy and T and B membrane markers.
    Belpomme D; Dantchev D; Karima AM; Lelarge N; Joseph R; Caillou B; Lafleur M; Mathé G
    Recent Results Cancer Res; 1976; (56):131-43. PubMed ID: 794955
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunologic approach to non-Hodgkin lymphomas and related leukemias. Analysis of the results of multiparameter studies of 425 cases.
    Lukes RJ; Parker JW; Taylor CR; Tindle BH; Cramer AD; Lincoln TL
    Semin Hematol; 1978 Oct; 15(4):322-51. PubMed ID: 366759
    [No Abstract]   [Full Text] [Related]  

  • 11. [Analysis of T-lymphocytes and B-lymphocytes].
    Nakagawa T; Yata J
    Nihon Rinsho; 1976; 34 suppl():2653-71. PubMed ID: 792528
    [No Abstract]   [Full Text] [Related]  

  • 12. PHA response of blood and lymph node lymphocytes in vitro in malignant lymphomas.
    Navone R; Stramignoni A
    Acta Haematol; 1974; 51(2):76-83. PubMed ID: 4217079
    [No Abstract]   [Full Text] [Related]  

  • 13. Suggested models of ecotaxopathy in lymphoreticular malignancy. A role for iron-binding proteins in the control of lymphoid cell migration.
    de Sousa M; Smithyman A; Tan C
    Am J Pathol; 1978 Feb; 90(2):497-520. PubMed ID: 304676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant disease of the lymphoid system in immunological perspective.
    Hansen JA; Good RA
    Hum Pathol; 1974 Sep; 5(5):567-99. PubMed ID: 4137052
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies of human leukemia and lymphoma cells by membrane immunofluorescence and mixed hemadsorption tests.
    Maruyama K; Dmochowski L; Bowen JM; Hales RL
    Tex Rep Biol Med; 1968; 26(4):545-65. PubMed ID: 4180625
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunological cell markers on lymphoblasts of patients with acute lymphatic leukemia.
    Schwenk HU
    Z Kinderheilkd; 1974; 118(2):87-95. PubMed ID: 4613037
    [No Abstract]   [Full Text] [Related]  

  • 17. [Malignant lymphoma--classification and pathophysiological characteristics of neoplastic cells based on the nature of cell membrane].
    Shimoyama M; Minato K; Kimura K
    Nihon Rinsho; 1976 May; 34(5):925-33. PubMed ID: 789941
    [No Abstract]   [Full Text] [Related]  

  • 18. Receptors for complement and immunoglobulin on human and animal lymphoid cells.
    Shevach EM; Jaffe ES; Green I
    Transplant Rev; 1973; 16():3-28. PubMed ID: 4590768
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cell reactions of immunological significance studied in bone marrow and lymph node cultures].
    Berceanu S; Gociu M; Răileanu-Moţoiu I
    Arch Roum Pathol Exp Microbiol; 1969; 28(2):453-64. PubMed ID: 5275846
    [No Abstract]   [Full Text] [Related]  

  • 20. 2. Lymphocyte surface marker studies in lymphoma and leukemia.
    Lowenthal RM
    Pathology; 1982 Jul; 14(3):283-9. PubMed ID: 6752833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.